Sexcord/ stromal ovarian tumors natural history, complications and prognosis: Difference between revisions
Line 37: | Line 37: | ||
*The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy]. | *The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy]. | ||
*[Subtype of disease/malignancy] is associated with the most favorable prognosis. | *[Subtype of disease/malignancy] is associated with the most favorable prognosis. | ||
*The prognosis varies with the subtypes of tumor | *The prognosis varies with the subtypes of tumor<ref name="pmid24416992">{{cite journal |vauthors=Elashry R, Hemida R, Goda H, Abdel-Hady el-S |title=Prognostic factors of germ cell and sex cord-stromal ovarian tumors in pediatric age: 5 years experience |journal=J. Exp. Ther. Oncol. |volume=10 |issue=3 |pages=181–7 |date=2013 |pmid=24416992 |doi= |url=}}</ref> | ||
*Sertoli-Leydig cell tumors have a 70 to 90 percent five-year survival overall and is mainly related to the stage and degree of histologic differentiation. | *Sertoli-Leydig cell tumors have a 70 to 90 percent five-year survival overall and is mainly related to the stage and degree of histologic differentiation. | ||
Revision as of 02:20, 7 April 2019
Sexcord/ stromal ovarian tumors Microchapters |
Differentiating Sexcord/ Stromal Ovarian Tumors from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Sexcord/ stromal ovarian tumors natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Sexcord/ stromal ovarian tumors natural history, complications and prognosis |
FDA on Sexcord/ stromal ovarian tumors natural history, complications and prognosis |
CDC on Sexcord/ stromal ovarian tumors natural history, complications and prognosis |
Sexcord/ stromal ovarian tumors natural history, complications and prognosis in the news |
Blogs on Sexcord/ stromal ovarian tumors natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
OR
Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
OR
Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
Natural History, Complications, and Prognosis
Natural History
- The symptoms of sexcord/ stromal ovarian tumors usually develop in the second/ third/ fourth decade of life, and start with symptoms such as:
- Adnexal mass
- Abdominal & pelvic symptoms
- Bloating
- Urinary urgency or frequency
- Dysphagia(difficulty eating) or feeling full quickly
- Pelvic or abdominal pain
- If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
Complications
- Common complications of [disease name] include:
- [Complication 1]
- [Complication 2]
- [Complication 3]
Prognosis
- Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [--]%.
- Depending on the extent of the tumor at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
- The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
- [Subtype of disease/malignancy] is associated with the most favorable prognosis.
- The prognosis varies with the subtypes of tumor[1]
- Sertoli-Leydig cell tumors have a 70 to 90 percent five-year survival overall and is mainly related to the stage and degree of histologic differentiation.